Literature DB >> 24424044

Liver-enriched transcription factor CREBH interacts with peroxisome proliferator-activated receptor α to regulate metabolic hormone FGF21.

Hyunbae Kim1, Roberto Mendez, Ze Zheng, Lin Chang, Juan Cai, Ren Zhang, Kezhong Zhang.   

Abstract

Lipid metabolism is tightly regulated by nuclear receptors, transcription factors, and cellular enzymes. In this study, we demonstrated that the liver-enriched transcription factor CREBH (cAMP-responsive element binding protein, hepatocyte specific) and peroxisome proliferator-activated receptor α (PPARα) function as binary transcriptional activators to regulate lipid metabolism by activating fibroblast growth factor 21 (FGF21), a hepatic hormone that regulates whole-body energy homeostasis. Gain- and loss-of-function studies indicated that CREBH regulates triglyceride and fatty acid metabolism in animals under fasting or on an atherogenic high-fat (AHF) diet. CREBH and PPARα act as interactive trans-activators that regulate each other for their expression. Activated CREBH protein interacts with PPARα to form a functional complex upon fasting or the AHF diet, and both factors are required for induction of the metabolic hormone FGF21. The CREBH-PPARα complex was found to bind to integrated CRE-PPAR-responsive element-binding motifs in the FGF21 gene promoter. Whereas CREBH and PPARα function in synergy to activate FGF21 gene expression, PPARα relies on CREBH to exert its trans-activation effect on FGF21. Supporting the key role of CREBH in regulating FGF21, infusion of recombinant FGF21 protein can reverse hypertriglyceridemia and hypoketonemia and partially rescue nonalcoholic steatohepatitis developed in the CREBH-null mice after the AHF diet. Our study demonstrated a transcriptional regulatory axis of CREBH-PPARα-FGF21 in maintaining lipid homeostasis under metabolic stress. The functional relationship between CREBH and PPARα in regulating FGF21 may represent an important transcriptional coactivation mechanism that orchestrates the processes of energy supply upon metabolic alteration.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24424044      PMCID: PMC3929740          DOI: 10.1210/en.2013-1490

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  29 in total

1.  Integrated genomic and proteomic analyses of gene expression in Mammalian cells.

Authors:  Qiang Tian; Serguei B Stepaniants; Mao Mao; Lee Weng; Megan C Feetham; Michelle J Doyle; Eugene C Yi; Hongyue Dai; Vesteinn Thorsson; Jimmy Eng; David Goodlett; Joel P Berger; Bert Gunter; Peter S Linseley; Roland B Stoughton; Ruedi Aebersold; Steven J Collins; William A Hanlon; Leroy E Hood
Journal:  Mol Cell Proteomics       Date:  2004-07-06       Impact factor: 5.911

2.  Identification of a novel FGF, FGF-21, preferentially expressed in the liver.

Authors:  T Nishimura; Y Nakatake; M Konishi; N Itoh
Journal:  Biochim Biophys Acta       Date:  2000-06-21

3.  The liver-enriched transcription factor CREBH is nutritionally regulated and activated by fatty acids and PPARalpha.

Authors:  Hirosuke Danno; Kiyo-aki Ishii; Yoshimi Nakagawa; Motoki Mikami; Takashi Yamamoto; Sachiko Yabe; Mika Furusawa; Shin Kumadaki; Kazuhisa Watanabe; Hidehisa Shimizu; Takashi Matsuzaka; Kazuto Kobayashi; Akimitsu Takahashi; Shigeru Yatoh; Hiroaki Suzuki; Nobuhiro Yamada; Hitoshi Shimano
Journal:  Biochem Biophys Res Commun       Date:  2009-12-16       Impact factor: 3.575

Review 4.  Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD).

Authors:  Giovanni Musso; Roberto Gambino; Maurizio Cassader
Journal:  Prog Lipid Res       Date:  2008-09-09       Impact factor: 16.195

5.  Hepatocyte nuclear factor 4alpha is implicated in endoplasmic reticulum stress-induced acute phase response by regulating expression of cyclic adenosine monophosphate responsive element binding protein H.

Authors:  Jennifer Luebke-Wheeler; Kezhong Zhang; Michele Battle; Karim Si-Tayeb; Wendy Garrison; Sodhi Chhinder; Jixuan Li; Randal J Kaufman; Stephen A Duncan
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

6.  Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.

Authors:  Naoto Matsuzawa; Toshinari Takamura; Seiichiro Kurita; Hirofumi Misu; Tsuguhito Ota; Hitoshi Ando; Masayoshi Yokoyama; Masao Honda; Yoh Zen; Yasuni Nakanuma; Ken-Ichi Miyamoto; Shuichi Kaneko
Journal:  Hepatology       Date:  2007-11       Impact factor: 17.425

7.  Fibroblast growth factor 21 corrects obesity in mice.

Authors:  Tamer Coskun; Holly A Bina; Michael A Schneider; James D Dunbar; Charlie C Hu; Yanyun Chen; David E Moller; Alexei Kharitonenkov
Journal:  Endocrinology       Date:  2008-08-07       Impact factor: 4.736

8.  Quantitative assessment of atherosclerotic lesions in mice.

Authors:  B Paigen; A Morrow; P A Holmes; D Mitchell; R A Williams
Journal:  Atherosclerosis       Date:  1987-12       Impact factor: 5.162

Review 9.  Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.

Authors:  Elisa Fabbrini; Shelby Sullivan; Samuel Klein
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

10.  Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.

Authors:  Alberto O Chavez; Marjorie Molina-Carrion; Muhammad A Abdul-Ghani; Franco Folli; Ralph A Defronzo; Devjit Tripathy
Journal:  Diabetes Care       Date:  2009-06-01       Impact factor: 19.112

View more
  56 in total

1.  Toll-like Receptor (TLR) Signaling Interacts with CREBH to Modulate High-density Lipoprotein (HDL) in Response to Bacterial Endotoxin.

Authors:  Aditya Dandekar; Yining Qiu; Hyunbae Kim; Jiemei Wang; Xia Hou; Xuebao Zhang; Ze Zheng; Roberto Mendez; Fu-Shin Yu; Ashok Kumar; Deyu Fang; Fei Sun; Kezhong Zhang
Journal:  J Biol Chem       Date:  2016-09-16       Impact factor: 5.157

2.  Hepatocyte-specific Sirt6 deficiency impairs ketogenesis.

Authors:  Lei Chen; Qinhui Liu; Qin Tang; Jiangying Kuang; Hong Li; Shiyun Pu; Tong Wu; Xuping Yang; Rui Li; Jinhang Zhang; Zijing Zhang; Ya Huang; Yanping Li; Min Zou; Wei Jiang; Tao Li; Meng Gong; Lu Zhang; Hua Wang; Aijuan Qu; Wen Xie; Jinhan He
Journal:  J Biol Chem       Date:  2018-12-10       Impact factor: 5.157

3.  Transcriptome Analysis of K-877 (a Novel Selective PPARα Modulator (SPPARMα))-Regulated Genes in Primary Human Hepatocytes and the Mouse Liver.

Authors:  Sana Raza-Iqbal; Toshiya Tanaka; Motonobu Anai; Takeshi Inagaki; Yoshihiro Matsumura; Kaori Ikeda; Akashi Taguchi; Frank J Gonzalez; Juro Sakai; Tatsuhiko Kodama
Journal:  J Atheroscler Thromb       Date:  2015-06-04       Impact factor: 4.928

4.  Transcriptional activation of Fsp27 by the liver-enriched transcription factor CREBH promotes lipid droplet growth and hepatic steatosis.

Authors:  Xu Xu; Jong-Gil Park; Jae-Seon So; Ann-Hwee Lee
Journal:  Hepatology       Date:  2015-01-28       Impact factor: 17.425

Review 5.  Sensing and signaling mechanisms linking dietary methionine restriction to the behavioral and physiological components of the response.

Authors:  Laura A Forney; Kirsten P Stone; Desiree Wanders; Thomas W Gettys
Journal:  Front Neuroendocrinol       Date:  2017-12-21       Impact factor: 8.606

6.  Lysine Acetylation of CREBH Regulates Fasting-Induced Hepatic Lipid Metabolism.

Authors:  Hyunbae Kim; Roberto Mendez; Xuequn Chen; Deyu Fang; Kezhong Zhang
Journal:  Mol Cell Biol       Date:  2015-10-05       Impact factor: 4.272

7.  Deficiency of the Mitochondrial NAD Kinase Causes Stress-Induced Hepatic Steatosis in Mice.

Authors:  Kezhong Zhang; Hyunbae Kim; Zhiyao Fu; Yining Qiu; Zhao Yang; Jiemei Wang; Deqiang Zhang; Xin Tong; Lei Yin; Jing Li; Jianmei Wu; Nathan R Qi; Sander M Houten; Ren Zhang
Journal:  Gastroenterology       Date:  2017-09-18       Impact factor: 22.682

8.  Interaction between stress responses and circadian metabolism in metabolic disease.

Authors:  Zhao Yang; Hyunbae Kim; Arushana Ali; Ze Zheng; Kezhong Zhang
Journal:  Liver Res       Date:  2017-09

9.  CREBH Maintains Circadian Glucose Homeostasis by Regulating Hepatic Glycogenolysis and Gluconeogenesis.

Authors:  Hyunbae Kim; Ze Zheng; Paul D Walker; Gregory Kapatos; Kezhong Zhang
Journal:  Mol Cell Biol       Date:  2017-06-29       Impact factor: 4.272

Review 10.  Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies.

Authors:  Giovanni Musso; Maurizio Cassader; Roberto Gambino
Journal:  Nat Rev Drug Discov       Date:  2016-01-22       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.